| Literature DB >> 36232097 |
Daniel Deimel1,2, Christine Firk3, Heino Stöver4, Nicolas Hees2, Norbert Scherbaum2, Simon Fleißner4.
Abstract
BACKGROUND: The measures taken to contain the COVID-19 pandemic have led to significant changes in people's daily lives. This paper examines changes in substance use during the first lockdown (March-July 2020) and investigates mental health burdens in substance users with increased consumption of alcohol, nicotine or tetrahydrocannabinol (THC) in Germany compared to users with unchanged or reduced consumption.Entities:
Keywords: COVID-19; mental health during lockdown; substance use during lockdown
Mesh:
Substances:
Year: 2022 PMID: 36232097 PMCID: PMC9566226 DOI: 10.3390/ijerph191912801
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
Sociodemographic data of the entire sample.
|
| % | |
|---|---|---|
|
| 2327 | |
| Female | 1595 | 67.3 |
| Male | 732 | 30.9 |
| Diverse | 35 | 1.5 |
|
| 2369 | |
| 18–24 | 351 | 14.8 |
| 25–34 | 485 | 20.5 |
| 35–44 | 477 | 20.1 |
| 45–54 | 435 | 18.4 |
| 55–64 | 439 | 18.5 |
| ≥65 | 182 | 7.7 |
|
| 2359 | |
| University or university of applied sciences diploma | 1228 | 51.8 |
| Completed vocational education | 285 | 12.0 |
| Completion of secondary school | 833 | 35.2 |
| Other/none | 13 | 0.5 |
|
| 2363 | |
| Full-time employed | 853 | 36.0 |
| Part-time employed | 605 | 25.5 |
| Student | 418 | 17.6 |
| Retired | 247 | 10.4 |
| Unemployed | 94 | 4.0 |
| Other | 146 | 6.2 |
|
| 2284 | |
| <1000 Euros | 604 | 25.5 |
| 1000–2000 Euros | 742 | 31.3 |
| 2000–3000 Euros | 599 | 25.3 |
| More than 3000 Euros | 339 | 14.3 |
|
| 2360 | |
| no financial losses | 1600 | 67.5 |
| very small financial losses | 401 | 16.9 |
| significant financial losses | 243 | 10.3 |
| very strong financial losses | 62 | 2.6 |
| the income has completely disappeared | 54 | 2.3 |
|
| 2354 | |
| 0 | 1746 | 73.7 |
| 1 | 241 | 10.2 |
| 2 | 269 | 11.4 |
| 3 | 74 | 3.1 |
| ≥4 | 24 | 0.9 |
|
| ||
| cardiovascular diseases/hypertension | 335 | 14.1 |
| weakened immune system | 261 | 11.0 |
| high obesity | 241 | 10.2 |
| chronic respiratory diseases | 173 | 7.3 |
| diabetes mellitus | 88 | 3.7 |
| cancer | 74 | 3.1 |
| chronic liver diseases | 21 | 0.9 |
Mental health.
| M | MD | SD | Min | Max | >Cut-Off | |
|---|---|---|---|---|---|---|
| Depressive Symptoms (PHQ-9) | 7.1 | 6 | 5.9 | 0 | 27 | 25.9% |
| Generalized Anxiety (GAD-7) | 6.6 | 5 | 5.3 | 0 | 21 | 23.3% |
| Loneliness | 1.6 | 1 | 2.2 | 0 | 11 | 23.3% |
| Burdens of social isolation during lockdown | 3.5 | 3 | 1.4 | 1 | 6 | -- |
|
| % | |||||
| Suicidal thoughts during lockdown | 938 | |||||
| Never | 580 | 61.8 | ||||
| rarely (once) | 193 | 20.6 | ||||
| sometimes (2 times) | 92 | 9.8 | ||||
| often (3–4 times) | 31 | 3.3 | ||||
| very often (5 times or more) | 42 | 4.5 | ||||
Sociodemographic data of persons who used alcohol, nicotine and THC in the last 12 months.
| Alcohol Consumption Last 12 Months | Nicotine Consumption | THC Consumption | ||||
|---|---|---|---|---|---|---|
|
| % |
| % |
| % | |
|
| 2148 | 895 | 465 | |||
| Female | 1458 | 66.1 | 565 | 63.1 | 267 | 57.4 |
| Male | 659 | 29.8 | 311 | 34.7 | 180 | 38.7 |
| Diverse | 31 | 1.4 | 19 | 2.1 | 18 | 3.9 |
|
| 2144 | 896 | 464 | |||
| 18–24 | 327 | 15.3 | 164 | 18.3 | 121 | 26.1 |
| 25–34 | 446 | 20.8 | 237 | 26.5 | 147 | 31.7 |
| 35–44 | 434 | 20.2 | 180 | 20.1 | 89 | 19.2 |
| 45–54 | 388 | 18.1 | 173 | 19.3 | 61 | 13.1 |
| 55–64 | 391 | 18.2 | 118 | 13.2 | 42 | 9.1 |
| ≥65 | 158 | 7.4 | 24 | 2.7 | 4 | 0.9 |
|
| 2145 | 890 | 462 | |||
| University or university of applied sciences diploma | 1145 | 53.4 | 405 | 45.5 | 212 | 45.9 |
| Completed vocational education | 249 | 11.6 | 116 | 13.0 | 55 | 11.9 |
| Completion of secondary school | 743 | 34.6 | 367 | 41.2 | 195 | 42.2 |
| Other/none | 8 | 0.4 | 2 | 0.2 | 0 | 0.0 |
|
| 2202 | 918 | 478 | |||
| Full-time employed | 809 | 36.7 | 338 | 36.8 | 170 | 35.6 |
| Part-time employed | 567 | 25.7 | 225 | 24.5 | 107 | 22.4 |
| Student | 401 | 18.2 | 207 | 22.5 | 131 | 27.4 |
| Retired | 215 | 9.8 | 46 | 5.0 | 16 | 3.3 |
| Unemployed | 79 | 3.6 | 49 | 5.3 | 22 | 4.6 |
| Other | 131 | 5.9 | 53 | 5.8 | 32 | 6.7 |
|
| 2076 | 881 | 458 | |||
| <1000 Euros | 541 | 26.1 | 261 | 29.6 | 165 | 36.0 |
| 1000–2000 Euros | 673 | 32.4 | 310 | 35.2 | 153 | 33.4 |
| 2000–3000 Euros | 549 | 26.4 | 208 | 23.6 | 100 | 21.8 |
| More than 3000 Euros | 313 | 15.1 | 102 | 11.6 | 40 | 8.7 |
|
| 2200 | 917 | 477 | |||
| no financial losses | 1487 | 67.6 | 585 | 63.8 | 289 | 60.6 |
| very small financial losses | 381 | 17.3 | 164 | 17.9 | 80 | 16.8 |
| significant financial losses | 222 | 10.1 | 115 | 12.5 | 68 | 14.3 |
| very strong financial losses | 61 | 2.8 | 32 | 3.5 | 18 | 3.8 |
| the income has completely disappeared | 49 | 2.2 | 21 | 2.3 | 22 | 4.6 |
|
| 2207 | 920 | 478 | |||
| cardiovascular diseases/hypertension | 300 | 13.6 | 108 | 11.7 | 41 | 8.6 |
| weakened immune system | 225 | 10.2 | 108 | 11.7 | 74 | 15.5 |
| high obesity | 214 | 9.7 | 85 | 9.2 | 37 | 7.7 |
| chronic respiratory diseases | 155 | 7.0 | 69 | 7.5 | 38 | 7.9 |
| diabetes mellitus | 79 | 3.6 | 31 | 3.4 | 9 | 1.9 |
| cancer | 69 | 3.1 | 19 | 2.1 | 4 | 0.8 |
| chronic liver diseases | 15 | 0.7 | 6 | 0.7 | 3 | 0.6 |
Substance use during first lockdown.
| Substance Use |
| % |
|---|---|---|
|
| ||
| Alcohol use last 12 months | 2207 | 94.0 |
| Alcohol use during lockdown | 2184 | |
| no consumption/less than before | 661 | 30.3 |
| unchanged | 900 | 41.2 |
| more than before | 623 | 28.5 |
|
| ||
| Nicotine use last 12 months | 920 | 45.6 |
| Nicotine use during lockdown | 907 | |
| no consumption/less than before | 298 | 32.9 |
| unchanged | 348 | 38.4 |
| more than before | 261 | 28.8 |
|
| ||
| THC use last 12 months | 478 | 23.5 |
| THC use during lockdown | 467 | |
| no consumption/less than before | 247 | 52.9 |
| unchanged | 124 | 26.6 |
| more than before | 96 | 20.6 |
Drug purchase during lockdown.
| Drug Purchase during Lockdown | THC | Amphetamine | Methamphetamine | Cocaine | Ecstasy | |||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| % |
| % |
| % |
| % |
| % | |
| Easier than before the lockdown | 4 | 2.1 | 2 | 7.1 | 1 | 12.5 | 1 | 3.4 | 2 | 8.0 |
| Same as before the lockdown | 155 | 82.9 | 18 | 64.3 | 4 | 50.0 | 23 | 79.3 | 17 | 68.0 |
| More difficult than before the lockdown, at a lower or the same price | 19 | 10.2 | 6 | 21.4 | 2 | 25.0 | 3 | 10.3 | 4 | 16.0 |
| More difficult than before the lockdown, at a higher price | 9 | 4.8 | 2 | 7.1 | 1 | 12.5 | 2 | 6.9 | 2 | 8.0 |
Alcohol use and mental health.
| Variable | No Increase in Alcohol Use | Increase in Alcohol Use | Test-Statistic | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95% CI | Effect size | ||||||||||
|
| M (SD) |
| M (SD) | LL | UL | Cohens d | |||||
|
| 1258 | 43.04 (15.88) | 606 | 40.36 (13.27) | 3.83 | 1.31 | 4.06 | 0.001 | 0.19 | ||
|
| |||||||||||
| Depression (PHQ-9 score) | 1210 | 6.30 (6.63) | 561 | 8.35 (5.91) | −6.89 | −2.63 | −1.47 | 0.001 | 0.37 | ||
| Anxiety (GAD-7 score) | 1190 | 5.81 (5.04) | 571 | 7.85 (5.39) | −7.58 | −2.57 | −1.51 | 0.001 | 0.39 | ||
| Loneliness (score) | 1290 | 2.56 (2.42) | 623 | 3.18 (2.68) | −4.87 | −0.87 | −0.37 | 0.001 | 0.25 | ||
|
| % |
| % | X2 | Phi | ||||||
|
| 2126 | ||||||||||
| Female | 1069 | 70.4 | 375 | 61.8 | 16.69 | 0.001 | 0.089 | ||||
| Male | 433 | 28.5 | 218 | 35.9 | |||||||
| Diverse | 17 | 1.1 | 14 | 2.3 | |||||||
|
| 2056 | ||||||||||
| <1.000 Euros | 386 | 26.3 | 150 | 25.5 | 0.49 | 0.921 | |||||
| 1.000–2.000 Euros | 480 | 32.7 | 188 | 32.0 | |||||||
| 2.000–3.000 Euros | 387 | 26.4 | 158 | 26.9 | |||||||
| More than 3.000 Euros | 215 | 14.6 | 92 | 15.6 | |||||||
|
| |||||||||||
| Depression (PHQ-9 ≥ 10) | 1298 | 28.2 | 535 | 36.1 | 11.09 | 0.001 | 0.08 | ||||
| Anxiety (GAD-7 ≥ 10) | 1436 | 21.5 | 571 | 34.0 | 33.76 | 0.001 | 0.13 | ||||
| Loneliness (cut-off ≥ 3) | 671 | 43.1 | 313 | 50.2 | 9.25 | 0.002 | 0.07 | ||||
|
| 1556 | 4.1 | 621 | 7.2 | 9.16 | 0.002 | 0.07 | ||||
|
| Mdn (IQR) | M |
| Mdn (IQR) | M | Mann–Whitney-U |
| ||||
|
| 1558 | 3 (2) | 3.36 | 623 | 4 (2) | 3.76 | 405,484.50 | 0.001 | 0.13 | ||
|
| 577 | 1 (1) | 1.59 | 275 | 1 (1) | 1.81 | 70,896.50 | 0.004 | 0.10 | ||
Nicotine consumption and mental health.
| Variable | No Increase in Nicotine Use | Increase in Nicotine Use | Test-Statistic | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95% CI | Effect size | ||||||||||
|
| M (SD) |
| M (SD) | LL | UL | Cohens d | |||||
|
| 450 | 40.08 (13.92) | 254 | 37.96 (12.66) | 1.99 | 0.34 | 4.19 | 0.023 | 0.16 | ||
|
| |||||||||||
| Depression (PHQ-9 score) | 435 | 7.24 (6.15) | 244 | 10.12 (6.28) | −5.82 | −3.86 | −1.91 | 0.001 | −0.47 | ||
| Anxiety (GAD-7 score) | 428 | 6.39 (5.41) | 242 | 9.49 (5.65) | −7.01 | −3.97 | −2.23 | 0.001 | −0.56 | ||
| Loneliness (score) | 460 | 2.81 (2.53) | 261 | 3.62 (2.50) | −4.15 | −1.19 | −0.43 | 0.001 | −0.32 | ||
|
| % |
| % | X2 | Phi | ||||||
|
| 883 | ||||||||||
| Female | 399 | 63.5 | 160 | 62.7 | 0.61 | 0.739 | |||||
| Male | 217 | 34.6 | 88 | 34.5 | |||||||
| Diverse | 12 | 1.9 | 7 | 2.7 | |||||||
|
| 869 | ||||||||||
| <1.000 Euros | 181 | 29.3 | 75 | 29.9 | 7.39 | 0.060 | |||||
| 1.000–2.000 Euros | 222 | 35.9 | 88 | 35.1 | |||||||
| 2.000–3.000 Euros | 134 | 21.7 | 69 | 27.5 | |||||||
| More than 3.000 Euros | 81 | 13.1 | 19 | 2.2 | |||||||
|
| |||||||||||
| Depression (PHQ-9 ≥ 10) | 180 | 32.4 | 112 | 46.9 | 14.96 | 0.001 | 0.14 | ||||
| Anxiety (GAD-7 ≥ 10) | 140 | 23.2 | 112 | 46.3 | 44.09 | 0.001 | 0.23 | ||||
| Loneliness (cut-off ≥ 3) | 302 | 46.7 | 161 | 61.7 | 16.60 | 0.001 | 0.14 | ||||
|
| 32 | 5.0 | 21 | 8.0 | 3.17 | 0.075 | |||||
|
| Mdn (IQR) | M |
| Mdn (IQR) | M | Mann–Whitney-U |
| ||||
|
| 645 | 3 (3) | 3.44 | 261 | 4 (2) | 3.97 | 66,379.50 | 0.001 | 0.17 | ||
|
| 275 | 1 (1) | 1.67 | 141 | 1 (1) | 1.92 | 17,111.00 | 0.028 | 0.11 | ||
THC consumption and mental health.
| Variable | No Increase in THC Use | Increase in THC Use | Test-Statistic | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 95% CI | Effect size | ||||||||||
|
| M (SD) |
| M (SD) | LL | UL | Cohens d | |||||
|
| 182 | 33.86 (12.49) | 94 | 34.87 (12.70) | 0.62 | −2.16 | 4.13 | 0.537 | |||
|
| |||||||||||
| Depression (PHQ-9 score) | 172 | 8.42 (5.95) | 92 | 10.63 (7.00) | −2.57 | −3.90 | −0.51 | 0.006 | −0.35 | ||
| Anxiety (GAD-7 score) | 179 | 7.69 (5.64) | 89 | 9.31 (5.95) | −2.18 | −3.09 | −0.16 | 0.015 | −0.28 | ||
| Loneliness (score) | 189 | 3.26 (2.45) | 96 | 3.70 (2.43) | −1.42 | −1.04 | −0.17 | 0.079 | |||
|
| % |
| % | X2 | Phi | ||||||
|
| 454 | ||||||||||
| Female | 209 | 58.2 | 54 | 56.8 | 0.07 | 0.968 | |||||
| Male | 136 | 37.9 | 37 | 38.9 | |||||||
| Diverse | 14 | 3.9 | 4 | 4.2 | |||||||
|
| 448 | ||||||||||
| <1.000 Euros | 130 | 36.7 | 35 | 37.2 | 3.06 | 0.383 | |||||
| 1.000–2.000 Euros | 112 | 31.6 | 37 | 39.4 | |||||||
| 2.000–3.000 Euros | 79 | 22.3 | 16 | 17.0 | |||||||
| More than 3.000 Euros | 33 | 9.3 | 6 | 6.4 | |||||||
|
| |||||||||||
| Depression (PHQ-9 ≥ 10) | 136 | 41.2 | 44 | 51.2 | 2.75 | 0.097 | |||||
| Anxiety (GAD-7 ≥ 10) | 114 | 32.7 | 36 | 40.4 | 1.91 | 0.167 | |||||
| Loneliness (cut-off ≥ 3) | 207 | 55.8 | 61 | 63.5 | 1.87 | 0.171 | |||||
|
| 28 | 7.6 | 12 | 12.5 | 2.36 | 0.124 | |||||
|
| Mdn (IQR) | M |
| Mdn (IQR) | M | Mann–Whitney-U |
| ||||
|
| 370 | 4 (2) | 3.62 | 96 | 4 (2) | 3.93 | 15,520.00 | 0.051 | |||
|
| 201 | 1 (1) | 1.74 | 57 | 1 (2) | 1.95 | 5264.50 | 0.295 | |||